Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life
Open accessThe DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Abstract
A diverse set of biological processes have been implicated in the pathophysiology of Alzheimer’s disease (AD) and related dementias. However, there is limited understanding of the peripheral biological mechanisms relevant in the earliest phases of the disease. Here, we used a large-scale proteomics platform to examine the association of 4877 plasma proteins with 25-year dementia risk in 10,981 middle-aged adults. We found 32 dementia-associated plasma proteins that were involved in proteostasis, immunity, synaptic function, and extracellular matrix organization. We then replicated the association between 15 of these proteins and clinically relevant neurocognitive outcomes in two independent cohorts. We demonstrated that 12 of these 32 dementia-associated proteins were associated with cerebrospinal fluid (CSF) biomarkers of AD , neurodegeneration, or neuroinflammation. We found that eight of these candidate protein markers were abnormally expressed in human postmortem brain tissue from patients with AD, although some of the proteins that were most strongly associated with dementia risk, such as GDF15, were not detected in these brain tissue samples. Using network analyses, we found a protein signature for dementia risk that was characterized by dysregulation of specific immune and proteostasis/autophagy pathways in adults in midlife ~20 years before dementia onset, as well as abnormal coagulation and complement signaling ~10 years before dementia onset. Bidirectional two-sample Mendelian randomization genetically validated nine of our candidate proteins as markers of AD in midlife and inferred causality of SERPINA3 in AD pathogenesis. Last, we prioritized a set of candidate markers for AD and dementia risk prediction in midlife.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330
Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Bowden, J., Davey Smith, G., & Burgess, S. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv080 · Cited by 9,816
Research works printed but not linked: 2
- Lezak M, Malec J, Manual for the Mayo-Portland Adaptability Inventory (MPAI-4) for adults, children and adolescents (2008). [Google Scholar]
- Heim A, AH 4 Group Test of General Intelligence (NFER-Nelson Publishing Company, 1970). [Google Scholar]
Cited by
Items 101–148 of 148
Walker, K. A., Blew, C., Duggan, M. R., Joynes, C., Gómez, G., Drouin, S. M., Cordon, J., Chen, J., Zhang, J., File, B., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.adx4852 · Cited by 2
Self-citationSaloner, R., Paolillo, E. W., VandeBunte, A. M., Cadwallader, C. J., Chen, C., Steffen, B. T., Bennett, D. A., Boeve, B. F., Rosen, H. J., Boxer, A. L., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.089188 · Cited by 2
Fornage, M., Tarraf, W., Xia, R., Ordonez, A., Sofer, T., Márquez, F., Thyagarajan, B., Talavera, G. A., Gallo, L. C., DeCarli, C. S., et al. (2025) · Aging · doi:10.18632/aging.206317 · Cited by 2
Self-citationLi, S., & Gong, M. (2023) · medRxiv · doi:10.1101/2023.10.23.23297376 · Cited by 2
Colinet, M., Chiver, I., Bonafina, A., Masset, G., Almansa, D., Valentin, E. D., Twizere, J., Nguyen, L., & Espuny-Camacho, I. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.16.589036 · Cited by 1
Proteomic Identification of Plasma Proteins Associated with Future Dementia Development
Bornhorst, J. A., & Algeciras‐Schimnich, A. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae004 · Cited by 1
Proteomics-based aging clocks in midlife and late-life and risk of dementiaPreprint
Sedaghat, S., Park, S., Walker, R. F., Wang, S., Liu, J., Hughes, T. M., Sabayan, B., Tang, W., Coresh, J., Pankow, J. S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5500348/v1 · Cited by 1
Self-citationTaneja, S. B., Boyce, R. D., Malec, S. A., Albert, S. M., Shaaban, C. E., Levine, A. S., Munro, P., Bian, J., Xu, J., Maraganore, D. M., et al. (2025) · medRxiv · doi:10.1101/2025.11.04.25338396 · Cited by 1
Dammer, E. B., Afshar, S., Bian, S., Seyfried, N. T., Levey, A. I., Fortea, J., & Johnson, E. C. B. (2026) · medRxiv · doi:10.64898/2026.02.14.26346321 · Cited by 1
Commensal fungi support granulocyte development
Bordon, Y. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00918-1
Dementia risk linked to blood-protein imbalance in middle age
Tozer, L. (2023) · Nature · doi:10.1038/d41586-023-02374-2
Tracy, D. K. (2023) · The British Journal of Psychiatry · doi:10.1192/bjp.2023.101
Advances in Proteomics Research in Postoperative Delirium
闫, 福. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.143893
A Neuroinflammatory View of Alzheimer’s Disease
Anisman, H., Hayley, S. P., & Kusnecov, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.00005-3
(2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23565-8.09996-8
Healthy lifestyles, plasma proteomic profile and long-term risk of dementiaPreprint
Shen, J., Wu, M., Huang, Y., Yan, M., Yang, Y., Xu, X., Zong, G., Yang, J., Li, X., Chen, H., et al. (2024) · medRxiv · doi:10.1101/2024.12.01.24317800
Self-citationShokat, S., Iqbal, R., Ali, M. A., Yaqub, A., Aslam, S., & Riaz, S. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04448-2
Drug Repositioning Based on Cerebrospinal Fluid Proteomes Using Connectivity Map Framework
Cortés, A., Romero-Murillo, S., Anaya‐Cubero, E., Cartas‐Cejudo, P., Extramiana, L., Lachén‐Montes, M., Fernández‐Irigoyen, J., & Santamaría, E. (2025) · Methods in molecular biology · doi:10.1007/978-1-0716-4462-1_22
Chu, X., Han, Z., Li, B., & Yang, T. (2025) · Medicine · doi:10.1097/md.0000000000042409
Homann, J., Korologou‐Linden, R., Viallon, V., Morgan, S. L., Dobričić, V. S., Deecke, L., Schessner, J. P., Smith-Byrne, K., Birtles, D., Zhao, Y., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5398619
Abdolkarimi, D., Liu, Y., Gilchrist, L., Calhas, S., Waters, S., Marshall, C. R., & Proitsi, P. (2025) · medRxiv · doi:10.1101/2025.08.29.25334731
“Recent studies have been exploring proteomic signatures associated with the incidence of dementia (10–12).”
InfluentialThe current landscape of prospective proteomics research into dementia using blood-based samples
Meineche, J. T., Wierer, M., & Jensen, M. K. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000001019
Ran, Z., Zhang, B., Luo, J.-X., Li, X.-Y., Zhu, T., Wu, Q.-L., Liu, L., Wang, D.-M., Mu, B.-R., & Lu, M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116139
Huang, C., Gao, S., Zheng, X., Song, X., Wu, J., Liao, K., Li, J., Lin, Y., Li, C., Lu, Y., et al. (2026) · MedComm · doi:10.1002/mco2.70595
“Previous studies have demonstrated that SERPINA3, as an immune related protein, is a biomarker for various diseases [ 40–42 ].”
Association of elevated circulating GDF15 and risk in acute retinal artery occlusion
Zhu, F., Liu, H., Shi, R., Xia, K., Wang, Y., Hu, L., Chen, T., Li, Y., Yang, A., & Xiao, X. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1707237
“The elevation of GDF15 levels has been extensively investigated and shown to correlate with ischemic stroke incidence and patient prognosis (10, 11).”
Ren, X., Zhang, X., Wang, W., Zhang, M., Bi, X., & Peng, W. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261423568
“9 However, the translation of these fi ndings into validated biomarkers for VCI has been particularly challenging.”
Yan, X., Liang, C., Zhou, Y., Hong, G., Li, C., Wang, K., Huang, Y., & Xiao, X. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1753692
Bettcher, B. M., Ren, S., Wang, Y., Carlson, N. E., Lippitt, W., McConnell, B. V., Wilson, E. N., Shapiro, A. L. B., Coughlan, C. M., Carlisle, T. C., et al. (2026) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2026.05.001
ProLM: a plasma proteomics pretrained model for the general population
Qiu, S., Zhao, M. H., Chen, X. T., ZHANG, Z., You, H., Sun, X., Guo, J., Liang, H., Guo, Y., Chen, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75507-6
Zhang, X., Huang, Q., Huang, J., Zhang, P., Feng, X., Li, Z., Raper, D. M. S., & Mao, C. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.07.040
Plasma proteomics reveals molecular overlap between physical activity and dementia risk
Saloner, R., Paolillo, E. W., VandeBunte, A. M., Cadwallader, C. J., Chen, C., Steffen, B. T., Bennett, D. A., Boeve, B. F., Rosen, H. J., Boxer, A. L., et al. (2026) · Brain Communications · doi:10.1093/braincomms/fcag287 · Cited by 2
Beydoun, M. A., Song, M., Yun, C., Hooten, N. N., Weiss, J., Beydoun, H. A., Duggan, M. R., Walker, K. A., Launer, L. J., Evans, M. K., et al. (2026) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70286 · Cited by 1
Self-citationJiménez‐Mausbach, M., Tijms, B. M., Paterson, C., & Refsgaard, J. C. (2026) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.70432 · Cited by 1
Peripheral GDF15 as an early biomarker for brain disorders: A large prospective cohort study
Guo, X., Wu, S., Sun, Z., Jia, T., Ouyang, Y., Zhang, M., Kou, C., & Bai, W. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111886 · Cited by 1
Guvatova, Z. G., Kobelyatskaya, A. A., Gorbunov, A., Pudova, E. A., & Moskalev, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177580
“A twenty-five-year follow-up study of middle-aged ARIC participants identified plasma protein markers of later-life dementia risk and implicated synaptic proteins [91], while Framingham Heart Study data yielded plasma protein risk scores for mild cognitive impairment and Alzheimer’s disease [92].”
Chen, C., Saloner, R., Paolillo, E. W., Cadwallader, C. J., VandeBunte, A. M., Lago, A. L., Rademakers, R., Ramos, E. M., Considine, C. M., Weıntraub, S., et al. (2026) · Neurology Open Access · doi:10.1212/wn9.0000000000000142
Longitudinal Dynamics of the Blood Proteome Within the Alzheimer Spectrum in Down Syndrome
Wagemann, O., Nübling, G., Sandkühler, K., Wlasich, E., Loosli, S. V., Prix, C., Stockbauer, A., Marth, L., Forte, A., Vöglein, J., et al. (2026) · Neurology · doi:10.1212/wnl.0000000000218494
Kowal, I., Scholz, S. W., Epstein, J., Traynor, B. J., Danielian, L. E., Hao, Y., Crook, J., Li, Z., Porter, K., Sellers, B., et al. (2026) · medRxiv · doi:10.64898/2026.09.02.26361977
Performance of protein panels is inflated across many biomarker studiesPreprint
An, L., Finney, C. A., Shvetcov, A., & Vogel, J. W. (2026) · medRxiv · doi:10.64898/2026.09.02.26362037
Stone, T. W., Clanchy, F. I. L., & Williams, R. O. (2026) · Biomolecules · doi:10.3390/biom16091300
“It is consistent with these arguments and studies of genetic polymorphisms that these can contribute to the disorders under consideration [70–74], including many with clear associations with epilepsy [75–78].”
Nie, T., 宋红梅, Shen, X., & Mao, L. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1885104 · Cited by 1
Qu, J., Yang, J., Li, W., Zeng, X., He, X., Guo, H., Lu, J., Jiang, X., Zhuang, X., Qian, C., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.08.022
Wang, J., Li, Z., Wang, T., Jiang, L., Sharif, A., Takechi, R., Li, T., Chong, L. H., Fang, F., Pang, Z., et al. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.09.013
The role of matrix metalloproteinases in Alzheimer's disease and small vessel disease
Nguyen, N., Huynh, S., Mroczko, B., & Glodzik, L. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261494579
Su, X., Mao, Y., Yang, C., Liao, H., Zhao, H., Zhang, Y., Wei, W., Bi, S., Liu, B., Fu, X., et al. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1974960
Self-citationQin, P., Finn, S., & Fancourt, D. E. (2026) · Brain Behavior and Immunity · doi:10.64898/2026.01.09.26343769
Metadata
- Authors
- Walker, K. A., Chen, J., Shi, L., Yang, Y., Fornage, M., Zhou, L., Schlosser, P., Surapaneni, A., Grams, M. E., Duggan, M. R., Peng, Z., Gomez, G. T., Tin, A., Hoogeveen, R. C., Sullivan, K. J., Ganz, P., Lindbohm, J. V., Kivimaki, M., Nevado-Holgado, A. J., Buckley, N., Gottesman, R. F., Mosley, T. H., Boerwinkle, E., Ballantyne, C. M., & Coresh, J.
- Affiliations
- National Institute on Aging (US)
- Johns Hopkins University (US)
- Novo Nordisk Research Centre Oxford (NNRCO), Oxford OX3 7FZ, UK.
- Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases (US)
- Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21210, USA.
- University of Mississippi Medical Center (US)
- Baylor College of Medicine (US)
- University of California, San Francisco (US)
- Broad Institute (US)
- Department of Mental Health of Older People, Faculty of Brain Sciences, University College London, London WC1E 6BT, UK.
- Department of Psychiatry, University of Oxford, Oxford OX1 2JD, UK.
- University of Oxford (GB)
- National Institute of Neurological Disorders and Stroke (US)
- Corresponding author
- Walker, Keenan A.
- Coresh, Josef
- ORCID
- Walker, Keenan A.
- Shi, Liu
- Yang, Yunju
- Fornage, Myriam
- Schlosser, Pascal
- Surapaneni, Aditya
- Grams, Morgan E.
- Duggan, Michael R.
- Peng, Zhongsheng
- Gomez, Gabriela T.
- Tin, Adrienne
- Hoogeveen, Ron C.
- Sullivan, Kevin J.
- Ganz, Peter
- Lindbohm, Joni V.
- Kivimaki, Mika
- Nevado-Holgado, Alejo J.
- Buckley, Noel
- Gottesman, Rebecca F.
- Mosley, Thomas H.
- Boerwinkle, Eric
- Ballantyne, Christie M.
- Coresh, Josef
- Venue
- Science Translational Medicine
- Published
- 2023-07-19
- Volume
- 15
- Issue
- 705
- Pages
- eadf5681-eadf5681
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- PMC
- PMC10665113
- OpenAlex
- W4384819023
- Cited by
- 148
- References
- 103
- Citations by year
- 2026: 42 · 2025: 56 · 2024: 39 · 2023: 11
- FWCI
- 29.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Commons-TMC (Texas Medical Center) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Funders
- GlaxoSmithKline
- Wellcome Trust (221854/Z/20/Z, 350426)
- European Commission (H2020 SC1, H2020)
- Rosetrees Trust
- Deutsche Forschungsgemeinschaft (192904750, CRC992)
- Albert-Ludwigs-Universität Freiburg
- Päivikki ja Sakari Sohlbergin Säätiö
- National Institutes of Health (5u01hl096899-08, 5u01hl096902-08, S011676, Z99 AG999999, H2020)
- Gillings School of Public Health
- Horizon 2020 Framework Programme (H2020-SC1)
- Medical Research Council (S011676, MR/R024227/1, MR/S011676/1, MRC S011676)
- Medizinische Fakultät der Albert-Ludwigs-Universität Freiburg
- National Institute on Aging (U01AG058589, RF1AG062553, U01AG052409, R01AG056477, RF1AG059421, ZIAAG000349, ZIAAG000348, P30AG066546)
- National Heart, Lung, and Blood Institute (HHSN268201700004I, HHSN268201700001I, HHSN268201700005C, HHSN268201700003I, U01HL096814, U01-HL-096899, R01HL087641, R01HL059367, R01HL134320, HHSN268201700005I, U01-HL-096902, HHSN268201700001C, U01HL096917, HHSN268201700002I, HHSN268201700003C, HHSN268201700002C, R01HL070825, HHSN268201700004C, U01HL096812, K24HL155861, R01HL086694)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124399, R01DK100446, R01DK115534, R01DK108803)
- National Institute of Neurological Disorders and Stroke
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR073178)
- National Center for Research Resources (UL1RR025005)
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, dementia risk, plasma proteins, biomarkers, proteomics, middle-aged adults, proteostasis, autophagy, neuroinflammation, cerebrospinal fluid biomarkers, GDF15, alpha-1-antichymotrypsin, coagulation, complement signaling, neurodegeneration, synaptic function, extracellular matrix, neuropsychological outcomes, dementia risk prediction
- MeSH terms
- Adult, Alzheimer Disease, Brain, Humans, Middle Aged, Biomarkers, Amyloid beta-Peptides, tau Proteins, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.